我要投票 前列康在中草药行业中的票数:870
· 外 推 电 报 ·
2026-01-08 08:07:32 星期四

【前列康是哪个国家的品牌?】

前列康是什么牌子?「前列康」是 浙江康恩贝制药股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人胡季强在1993-01-09期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力前列康品牌出海!将品牌入驻外推网,定制前列康品牌推广信息,可以显著提高前列康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

“前列康”作为江康恩贝制药股份有限公司主导植物药产品,已成国内中药前列腺治疗领域领先品牌,并荣获“中国驰名商标”荣誉。

康恩贝前列康®,是中国第一个纯花粉制剂,第一个对前列腺疾病具有治养结合的药物。列康®的花粉中富含植物生长素(EA-10)、阿魏酸γ—丁二胺(P5)、黄酮类化合物、微量元素Zn2+、Mn2+等。EA-10有着抗雄性激素、抗炎症的作用;P5主要能缩小前列腺体积、松弛平滑肌、扩张尿道等功效;氨基酸、微量元素等对于前列腺的日常保养有着积极作用。上市27年,距今未发现严重不良反应报道。

对慢性前列腺炎的急性症状,前列康®可与消炎药及镇痛药联用;对BPH的急性症状,可与α受体抑制剂联用,能更快更安全。

前列康®为国家基本药物目录品种、中药保护品种、国家医保品种,日平均治疗费约2.6元钱,价格实惠,一个月为一疗程、坚持服用疗效好。彻底摆脱夜尿、尿频、尿急、尿不尽、等排尿困难症状。

浙江康恩贝制药股份有限公司为国家火炬计划重点高新技术企业、国家创新型企业、国家知识产权试点企业、国家中药五十强企业、科技部中药现代化科技产业基地先进单位、浙江省“五个一批”重点骨干企业、浙江省专利示范企业、浙江省创新型示范企业,建有国家认定企业技术中心、国家博士后科研工作站、浙江省中药制药技术重点实验室、省级研发中心和技术中心,是浙江省首批重点企业技术创新团队。公司拥有一支由博士、硕士和高、中级职称的技术人员组成的实力雄厚、专注于现代植物药和特色化学药研发的团队,与国内外知名科研机构、大专院校建立了长期的战略合作伙伴和战略联盟,已建立新药研发的多个技术平台,通过聘请行业权威人士组成研发专家委员会,在心脑血管系统用药、泌尿系统用药、抗糖尿病用药、呼吸道系统用药、消化系统用药和抗感染药等药物的研发,以及植物提取分离和结构改造、新型药物释放系统应用等诸多方面,以现代植物药、特色化学药和保健食品发展为主线,研发具有自主知识产权的新药,在药材种植、原料药和植物提取、新药研发、制剂生产、市场营销等各环节,已建立起规范高效的产业体系。
公司自成立之日起就以市场为导向,建立起了“聚焦、扁平、高效”的营销网络体系,并全力拓展国际市场,已培育出了“前列康”、“天保宁”、“可达灵”、“刻停片”等植物药品牌以及“阿乐欣”、“金奥康”等化学药知名产品品牌,在同类竞争产品中已树立起了较具领导优势的市场地位。

公司历来十分重视产品品牌和企业品牌的培育和保护,在泌尿系统及心脑血管系统等多个领域树立了较为强势的品牌,如今,公司已成为浙江省拥有著名商标和名牌产品最多的企业之一。其中,“康恩贝”、“前列康”被认定为中国驰名商标,“天保宁”作为中国第一个符合国际质量标准的现代植物药制剂,已成为中国银杏叶制剂第一品牌;“可达灵”属国家中药保护独家品种,是公司又一个心脑血管领域的战略性品牌。此外,“金康”、“金奥康”、“贝贝”、“元邦”等均在各自领域拥有较高的品牌知名度。

展望未来,公司将秉承“集天下才智,创宏伟事业,为人类健康、献至诚至爱”的企业宗旨,倡导并培育公司和谐与激情并进的文化氛围,一如既往地致力于现代植物药领域的创新发展,发扬“艰苦创业、开拓进取、团结拼搏、创新发展、追求卓越”的康恩贝精神,发挥公司整体实力和品牌优势,在推进中药现代化、国际化的进程中,致力于将康恩贝打造成中国最具品牌价值的医药企业之一和世界植物药领军企业!

英文翻译:As the leading plant medicine product of jiangkang enbe Pharmaceutical Co., Ltd., "QianLieKang" has become a leading brand in the field of traditional Chinese medicine prostate treatment, and won the honor of "China famous brand". Kangenbeiqianliekang ®, the first pure pollen preparation in China, is the first drug with a combination of treatment and nutrition for prostate diseases. The pollen of Likang is rich in plant auxin (EA-10), ferulic acid γ - butanediamine (P5), flavonoids, trace elements Zn2 +, Mn2 +, etc. EA-10 has the effect of anti androgen and anti-inflammatory; P5 can reduce the volume of prostate, relax smooth muscle, dilate urethra, etc.; amino acids, trace elements, etc. have a positive effect on the daily maintenance of prostate. No serious adverse reactions have been reported since 27 years of listing. For the acute symptoms of chronic prostatitis, QianLieKang can be combined with anti-inflammatory drugs and analgesics; for the acute symptoms of BPH, QianLieKang can be combined with α receptor inhibitors, which is faster and safer. QianLieKang (QianLieKang) is a national essential drug catalog, traditional Chinese medicine protection and national medical insurance variety, with an average daily treatment cost of about 2.6 yuan, affordable price, one month as a course of treatment and good therapeutic effect. Thoroughly get rid of the night urine, frequency of urination, urgency of urination, endless urination, and other dysuria symptoms. Zhejiang Kangenbei Pharmaceutical Co., Ltd. is a key high-tech enterprise of the national torch plan, a national innovative enterprise, a national intellectual property pilot enterprise, a top 50 enterprise of the national traditional Chinese medicine, an advanced unit of the modern science and technology industrial base of traditional Chinese medicine of the Ministry of science and technology, a "five in one batch" key backbone enterprise of Zhejiang Province, a patent demonstration enterprise of Zhejiang Province, and an innovative demonstration enterprise of Zhejiang Province The state recognized enterprise technology center, National Postdoctoral research workstation, Zhejiang Key Laboratory of traditional Chinese medicine pharmaceutical technology, provincial R & D center and technology center are the first batch of key enterprise technology innovation teams in Zhejiang Province. The company has a strong team composed of doctors, masters and technicians with senior and intermediate professional titles, which focuses on the research and development of modern plant medicine and characteristic chemical medicine. It has established long-term strategic partners and strategic alliances with well-known scientific research institutions and colleges at home and abroad. It has established multiple technical platforms for new drug research and development, and has hired industry authorities to form research and development experts The committee, in many aspects such as the research and development of drugs for cardiovascular and cerebrovascular system, urinary system, anti diabetes, respiratory system, digestive system and anti infection, as well as the application of plant extraction, separation and structural transformation, and new drug release system, takes the development of modern plant medicine, characteristic chemical medicine and health food as the main line, and researches and develops products with independent knowledge A standardized and efficient industrial system has been established for the development of new drugs, including the cultivation of medicinal materials, the extraction of APIs and plants, the research and development of new drugs, the production of preparations, and marketing. Since its establishment, the company has been guided by the market, established a "focused, flat and efficient" marketing network system, and made great efforts to expand the international market. It has cultivated "QianLieKang", "Tianbaoning", "Daling", "keting tablet" and other plant medicine brands, as well as "alexin", "jinaokang" and other famous chemical product brands, which have been established in similar competitive products It has established a leading market position. The company has always attached great importance to the cultivation and protection of product brand and enterprise brand, and has established a relatively strong brand in many fields such as urinary system and cardiovascular and cerebrovascular system. Now, the company has become one of the enterprises with the most famous trademarks and famous brand products in Zhejiang Province. Among them, "Kangenbei" and "QianLieKang" are recognized as China's well-known trademarks, "Tianbaoning", as China's first modern botanical drug preparation meeting the international quality standards, has become the first brand of Ginkgo biloba preparations in China; "reachable" is the exclusive variety of national traditional Chinese medicine protection, and is another strategic brand in the cardio cerebrovascular field of the company. In addition, "Jinkang", "jinaokang", "Beibei" and "Yuanbang" have high brand awareness in their respective fields. Looking forward to the future, the company will adhere to the enterprise tenet of "gathering the wisdom of the world, creating a grand cause, contributing to human health and sincere love", advocate and cultivate a harmonious and passionate cultural atmosphere of the company, as always, commit to the innovation and development in the field of modern plant medicine, and carry forward the conerby spirit of "hard work, pioneering, unity and hard work, innovation and development, and pursuit of excellence" In the process of promoting the modernization and internationalization of traditional Chinese medicine, we are committed to building Kangenbei into one of the most famous pharmaceutical enterprises in China and the world leader in plant medicine!

本文链接: https://www.waitui.com/brand/cc5d91b4b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

具身机器人也有自己的保单,险企竞逐机器人保险业务

机器人租赁市场需求旺盛,也催生了大量的保险保障需求。多位业内人士认为,机器人保险作为新型保险产品,其发展成熟需要大量的数据支撑,如果仅与单一企业合作或投保单一设备,数据积累会比较慢。通过与租赁平台等合作,不仅可以获得批量保单,也有利于实现数据的快速积累,为精算定价、风险理赔提供数据支撑,机器人保险有望迎来新增长极。不过,机器人保险在我国还处在起步阶段,发展过程中的风险评估难、产品适配差、责任界定难、风控能力弱等问题,还需要多方协作、共同破局。(上证报)

8分钟前

日本11月份实际工资同比下降2.8%,为去年1月以来最大降幅

日本政府周四公布的初步数据显示,受一次性奖金大幅减少的拖累,日本11月份实际工资出现了自去年1月以来的最大降幅。与此同时,通胀超过工资增长的潜在趋势没有改变,这给日本央行带来了挑战。此前日本央行已发出信号,将在今年继续加息。(新浪财经)

8分钟前

机构称2026年铜市上行趋势明朗

2025年年末,国内铜现货(电解铜)价格突破100000元/吨关口,为铜市注入强劲动力。与此同时,2026年长单签订博弈进入白热化,国内提价潮、外贸溢价攀升、铜精矿加工费(TC/RC)低位僵持等现象集中出现。业内人士表示,这既反映出市场对供需格局的预判,也预示着2026年铜价或开启新一轮上涨行情。(中证网)

8分钟前

中信建投:商业航天产业有望进入新纪元

36氪获悉,中信建投指出,当前商业航天产业在国家政策支持和产业技术突破共同助力下,有望进入新纪元。商业航天产业涉及信息化的主要环节包括(1)遥感及其应用;(2)卫星测运控系统;(3)CAE仿真/卫星测试;(4)星际传输处理模块、通信模组、数据处理平台等;新场景扩展层面关注太空算力。此外,我们认为当前商业航天发展是国企与民营企业共振周期。

8分钟前

耐心资本布局硬科技,社保科创基金多地落子

长期资本正在重塑科技创新领域的投资生态。全国社会保障基金理事会官网显示,目前已成立的5只社保科创基金定位均为“服务国家发展的市场化基金”,旨在疏通金融资源进入实体经济的渠道,增加支持科技创新和产业创新深度融合的有效投资,在服务科技强国建设、助力科创企业成长中实现基金安全和保值增值。多位专家介绍,从浙江首发到江苏、福建、湖北、四川相继跟进,社保科创基金的迅速布局,标志着国家长期、耐心资本与区域创新战略的系统性对接已进入加速布局阶段。(上证报)

8分钟前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询